2.24 Utilization of Cyp450 Genotyping in the Treatment of Adolescent Mood Disorders: A Look at the Impact Within an Outpatient Setting

Abstract

This 2-arm study sought to evaluate the efficacy of using pharmacogenomic (PGx) testing in the treatment of mood disorders in children and adolescents. We examined whether using CYP450 genotyping to guide selection of pharmacologic agents in a treatment-as-usual setting resulted in better outcomes than unguided treatment.